Meanwhile, restoring HBA1 expression via gene therapy or epigenetic modulation may help counteract the metabolic and hypoxic advantages of HNSCC cells, potentially limiting tumor survival and progression. The gene discussed is HBA1; the disease is head and neck squamous cell carcinoma.